SPRY — ARS Pharmaceuticals, Inc. stock price, charts and financials

QT21ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.32
-0.14-2.56%
OverviewShort InterestFilings
SPRYQT21ARS Pharmaceuticals, Inc.·NASDAQ
5.32-2.56%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20268-KCurrent report
Jul 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 07, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 01, 20263Initial statement of beneficial ownership
May 15, 202610-QQuarterly report
May 15, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20268-KCurrent report
Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026ARSAnnual report to shareholders
Apr 29, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 275
Page
▼
/ 11